Pfizer/Myovant take relugolix contraceptive combination pill...

Pfizer and Myovant have begun a late-stage trial of their potential uterine fibroid drug relugolix, as part of a contraceptive combination tablet. 

What can we learn from women’s health data?

Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health's Dr Lucy Mackillop.

VivoPlex raises funding to develop intra-uterine sensor

VivoPlex, a UK based firm specialising in fertility and women’s health, has raised £3.9m to develop an intra-uterine sensor system and generate clinical data that could be used for European

Hormonal drug shortages in UK ‘harming women’, say doctors

Merck & Co spin off could start a trend in big pharma

Merck & Co’s strategy to spin off its older drugs and biosimilars into a new stand-alone business will be closely watched by other pharma companies considering the same move, analysts h

Merck to spin old drugs into ‘NewCo’ focused on generics, wo...